EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C24H32ClFO5 |
| Net Charge | 0 |
| Average Mass | 454.966 |
| Monoisotopic Mass | 454.19223 |
| SMILES | [H][C@@]12C[C@@]3([H])OC(C)(C)O[C@@]3(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@@]21C |
| InChI | InChI=1S/C24H32ClFO5/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,26)17(28)11-22(16,4)24(19,31-20)18(29)12-25/h9,15-17,19,28H,5-8,10-12H2,1-4H3/t15-,16-,17-,19+,21-,22-,23-,24+/m0/s1 |
| InChIKey | MUQNGPZZQDCDFT-JNQJZLCISA-N |
| Roles Classification |
|---|
| Biological Role: | SMO receptor agonist An agonist that enhances the action of smoothened (SMO) receptor. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| Halcinonide (CHEBI:31663) has role SMO receptor agonist (CHEBI:131809) |
| Halcinonide (CHEBI:31663) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| Halcinonide | KEGG COMPOUND |
| halog | DrugCentral |
| alcinonide | DrugCentral |
| halcimat | DrugCentral |
| halciderm | DrugCentral |
| Citations |
|---|